Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Combatting HIV Or Other STIs Early (CHOOSE)

Westat · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA) · NCT07510048

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 13–24 · Men only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
200
US sites recruiting
6
Study start
September 16, 2026
Record last updated
October 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.

Being studied: Standard of care and PrEP Choice at Enrollment; Standard of care followed by PrEP Choice at Month 9

Conditions: HIV; STIs; STIs Prevention; HIV Prevention

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age 13-24 years, inclusive;
  • Self-reports being at increased likelihood for HIV acquisition, defined as having anal sex with a male in their lifetime;
  • Owns an iOS or Android Smartphone and able to access all elements of the PrEP Choice package;
  • Not currently on PrEP and interested in learning more about PrEP;
  • Is not living with HIV;
  • Weighs at least 35 kg;
  • Willing to receive PrEP care from a provider at a participating ATN SC;
  • Able to understand, read, and speak English;
  • Able to participate at the study site; and
  • Willing and able to provide written informed consent.
  • If of legal age or otherwise able to provide independent informed consent as determined by local law and consistent with IRB policies: Willing and able to provide written informed consent for study participation.
  • If not of legal age or otherwise not able to provide independent informed consent as determined by local law and consistent with IRB policies: Parent or legal guardian is willing and able to provide written informed consent for study participation and potential participant is willing and able to provide written assent for study participation.

Exclusion Criteria

  • Female;
  • In a mutually monogamous sexual relationship with a partner not living with HIV for the past 12 months;
  • Currently participating in an interventional trial of PrEP agents, or prior enrollment in HPTN 083, HPTN 083-01, or any other study of long-acting PrEP (including PURPOSE- 2 lenacapavir study);
  • Plan to move within 18 months to an area inaccessible to a participating ATN SC;
  • An employee of the participating SC; or
  • Any concurrent participation in other clinical trials or behavioral intervention studies without prior approval from the protocol team.
  • Any other medical, behavioral, or other conditions that in the opinion of the SC Project Lead could interfere with adherence to study procedures or the individual's ability to remain in the study for an 18-month period or compromise interpretation of study results.

Recruiting US locations

  • San Francisco Department of Public Health

    San Francisco, CA 94102

    Site contact: Emily Schaeffer · 628-217-7456 · emily.schaeffer@sfdph.org

  • Children's National Medical Center

    Washington D.C., DC 20010

    Site contact: Justin Unternaher · 202-476-1030 · junternahe@childrensnational.org

  • University of South Florida

    Tampa, FL 33612

    Site contact: Elizabeth Enriquez-Bruce · 813-250-2574 · enriquezbruce@usf.edu

  • University Illinois Chicago

    Chicago, IL 60612

    Site contact: Rachel Jackson · 312-996-6018 · rjacks34@uic.edu

  • Tulane University

    New Orleans, LA 70112

    Site contact: Leslie Kozina · 504-988-5348 · lkozina@tulane.edu

  • St. Jude Children's Research Hospital

    Memphis, TN 38015

    Site contact: Mary Dillard · 901-595-4083 · Mary.dillard@stjude.org

Study contacts (from the official record)

  • Erin Healey · 301-610-8703 · ErinHealey@westat.com
  • Nancy Liu · 718-980-3937 · NancyLiu@westat.com
Combatting HIV Or Other STIs Early (CHOOSE) (NCT07510048) | Bored Studies